Live feed
Filing
SC 13G/A
SC 13G/A0001425738-18-000013·LUMOS PHARMA, INC.
Schedule 13G ownership disclosure
NEWLINK GENETICS CORP
Security class unavailable · CUSIP: 651511107
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,096,490
- Percent of class
- 5.6500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001425738-18-000013
- Form type
- SC 13G/A
- Filer
- LUMOS PHARMA, INC.
- CIK
- CIK 1126234
- Filed
- Feb 14, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership